Asston Pharmaceuticals IPO: Massive Investor Demand!

IPO Details: • Company: Asston Pharmaceuticals • Issue Size: ₹27.56 crore • Price Band: ₹115–₹123 per share • Total Shares Offered: 22.41 lakh shares • IPO Dates: July 9–11 • Listing Date: July 16 on BSE SME • Allotment Date: July 14 Subscription Numbers: • Overall Subscription: 173.53 times • Retail Investors: 172.14x • Non-Institutional Investors (NII): 261.67x • Qualified Institutional Buyers (QIB): 85.76x • Total Shares Bidded: 27.86 crore vs 16.06 lakh available Grey Market Premium (GMP): • GMP currently around ₹30 • Implies a 24% premium over upper price band (₹123) • Expected listing price ≈ ₹153 Where Funds Will Go: • Buy machinery for the manufacturing plant • Increase working capital • Repay some debts • General corporate use What the Company Does: • Based in Navi Mumbai • Makes pharma formulations and nutraceutical products • Supplies to India and African markets • Holds 150+ registered trademarks • Also does contract manufacturing for other pharma brands Why It’s a Buzz? • Extremely high demand across all investor categories • GMP signals strong listing expectations • Investors showing confidence in pharma & export-driven businesses Note: As it’s a BSE SME listing, only investors with a demat account and eligibility to trade SME stocks can buy/sell it post-listing. Always evaluate risks before investing post-listing.